BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Innovating Novel Combination Therapies and Maximising Preclini
 cal and Clinical Development to Improve Glioblastoma Targeting and Increa
 se Investment Opportunities to Ultimately Bring Efficacious Therapies to 
 Patients in NeedThe glioblastoma drug development space has been energize
 d by Merck's acquisition of Modifi Bio last December. This landmark deal 
 has sparked renewed hope in a field long challenged by limited investment
  and clinical breakthroughs.\n\nLooking ahead to 2026\, it's crucial to s
 ustain this momentum. The 7th Glioblastoma Drug Development Summit is you
 r essential platform for accelerating new treatments and continuing this 
 vital progress.\n\nJoin us for a definitive\, 3-day summit designed to ac
 celerate progress. With groundbreaking content and six deep-dive workshop
 s\, you'll connect with over 90 leading experts from every corner of the 
 field - from biotech to investment. This is your opportunity to uncover t
 he latest advancements\, learn how to overcome funding challenges\, and e
 xplore the transformative role of AI in glioblastoma.\n\nTogether\, we'll
  unlock actionable insights\, forge powerful partnerships\, and secure th
 e future of your pipeline and move towards the delivery of transformative
  therapies for one of the most devastating and underserved cancers.\n\nDa
 te and Time: Tuesday\, 17 February 2026 at 08:30 - Thursday\, 19 February
  2026 at 17:30\n
DTEND:20260219T173000
DTSTAMP:20260514T153458Z
DTSTART:20260217T083000
LOCATION:The Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\
 , Massachusetts\, 02142\,
SEQUENCE:0
SUMMARY:Innovating Novel Combination Therapies and Maximising Preclinical 
 and Clinical Development to Improve Glioblastoma Targeting and Increase I
 nvestmen...
UID:c0dcb049-ca77-4b15-8baa-b9550b541a20
END:VEVENT
END:VCALENDAR